Clinical effect of pemetrexed as the first‐line treatment in Chinese patients with advanced anaplastic lymphoma kinase‐positive non‐small cell lung cancer

BACKGROUND: The efficacy of pemetrexed‐based first‐line chemotherapy in anaplastic lymphoma kinase (ALK)‐positive non‐small cell lung cancer (NSCLC) has been demonstrated in several studies; however, there is a lack of data from Chinese populations. METHODS: The clinicopathological characteristics a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Di, Hao, Xuezhi, Wang, Yan, Xing, Puyuan, Li, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930965/
https://www.ncbi.nlm.nih.gov/pubmed/27385988
http://dx.doi.org/10.1111/1759-7714.12353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930965/
https://www.ncbi.nlm.nih.gov/pubmed/27385988
http://dx.doi.org/10.1111/1759-7714.12353

Ejemplares similares